Staphylococcus aureus Prosthetic Valve Endocarditis: Optimal Management and Risk Factors for Death
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The mortality rate associated with Staphylococcus aureus prosthetic valve endocarditis (PVE) remains high. To identify clinical events associated with an increased risk of death among patients with S. aureus PVE and to evaluate the role of valve replacement surgery in reducing mortality, we conducted a retrospective cohort study of patients who met strict criteria for definite S. aureus PVE. The primary endpoint for the study was survival at 3 months from the date of diagnosis. S. aureus PVE was diagnosed in 33 patients. Of these, 14 (42%) died within 90 days of the diagnosis. Cardiac complications were detected in 22 (67%), and central nervous system (CNS) complications were detected in 11 (33%). A stepwise logistic regression multivariate model demonstrated that cardiac complications, but not CNS complications, were associated with increased mortality and that performing valve replacement surgery during antibiotic therapy was associated with decreased mortality. These associations were confirmed by using a Cox proportional hazards model with time-dependent covariates to control for survival bias. Performing valve replacement surgery during antimicrobial therapy will reduce the mortality among patients with S. aureus PVE, even those without evidence of cardiac complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early cardiac surgical interventions play an important role in maximizing outcomes in S aureus PVE, 186 especially in the presence of heart failure.”
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Prosthetic valve endocarditis.
Ivert, T. S., Dismukes, W. E., Cobbs, C. G., Blackstone, E. H., Kirklin, J. W., & Bergdahl, L. A. (1984) · Circulation · doi:10.1161/01.cir.69.2.223 · Cited by 498 · cited 1×
“7% within 60 months after surgery [1-4].”
NEUROLOGIC COMPLICATIONS OF BACTERIAL ENDOCARDITIS
PRUITT, A. A., RUBIN, R. H., KARCHMER, A. W., & DUNCAN, G. W. (1978) · Medicine · doi:10.1097/00005792-197807000-00004 · Cited by 419
Self-citationSurgical management of infective endocarditis associated with cerebral complications
Eishi, K., Kawazoe, K., Kuriyama, Y., Kitoh, Y., Kawashima, Y., & Omae, T. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70038-2 · Cited by 299
Risk factors for the development of prosthetic valve endocarditis.
Calderwood, S. B., Swinski, L. A., Waternaux, C. M., Karchmer, A. W., & Buckley, M. J. (1985) · Circulation · doi:10.1161/01.cir.72.1.31 · Cited by 271 · cited 2×
“Early PVE was defined as that occurring < 12 months after valve implantation, whereas late PVE was defined as that beginning > 12 months after valve implantation, as previously defined [2].”
MethodSelf-citationStroke in infective endocarditis.
Hart, R. G., Foster, J. W., Luther, M. F., & Kanter, M. C. (1990) · Stroke · doi:10.1161/01.str.21.5.695 · Cited by 254 · cited 1×
“aureus PVE [22-24].”
Masur, H., & Johnson, W. D. (1980) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)37824-9 · Cited by 202
Valve replacement in patients with endocarditis and acute neurologic deficit
Gillinov, A. M., Shah, R. V., Curtis, W. E., Scott Stuart, R., Cameron, D. E., Baumgartner, W. A., & Greene, P. S. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(96)00014-8 · Cited by 186 · cited 2×
“Recent studies have suggested that worsening of the CNS deficit may be diminished by delaying surgery for 10-14 days after cerebral infarction and for perhaps as long as 4 weeks after cerebral hemorrhage [19, 20, 25].”
Background
Cited by
Items 101–155 of 155
Medical treatment of endocarditis
Abrutyn, E., Cabell, C. H., Fowler, V. G., Hoen, B., Miró, J. M., Mestres, C. A., Sexton, D. J., & Corey, G. R. (2007) · Current Infectious Disease Reports · doi:10.1007/s11908-007-0043-y · Cited by 5
“In fact, early surgery may be associated with improved outcome regardless of whether the infecting organism responds to antimicrobial therapy [ 39 ].”
BackgroundCurrent Opinions in Infective Endocarditis
Loupa, C. V., & Mentzikof, D. (2002) · Cited by 5
Palraj, R., Knoll, B. M., Baddour, L. M., & Wilson, W. R. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00083-7 · Cited by 4
Nagaratnam, N., Nagaratnam, K., & Cheuk, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-32700-6_7-1 · Cited by 4
Staphylococcal Infection: Emerging Clinical Syndromes
John, J. F. (2004) · Elsevier eBooks · doi:10.1016/b978-1-898563-96-9.50006-3 · Cited by 4
Capilla, E., Poyet, R., Tortat, A. V., Marchi, J., Brocq, F.-X., Pons, F., Kerebel, S., Jégo, C., Mayet, A., & Cellarier, G. R. (2017) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2016.09.042 · Cited by 4
Clinical Syndromes of Device-Associated Infections
Zaoutis, T. E., & Coffin, S. E. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-3468-8.50108-5 · Cited by 6
Candida parapsilosis Prosthetic Valve Endocarditis: A Multifaceted Problem
Yatin, M., & Deswal, V. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23941 · Cited by 4
“Clin Infect Dis Off Publ Infect Dis Soc Am 1998;26(6):1302–1309.”
BackgroundNew Insights and Updates for Established Entities
(2003) · Springer eBooks · doi:10.1007/0-306-47926-5_1 · Cited by 4
CE Forum: Differential Diagnosis of Infective Endocarditis
Shumann, L., & Thornton, S. E. (2000) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2000.tb00181.x · Cited by 3
Pallasch, J., Takahashi, M., Taubert, K. A., Shulman, S. T., Burns, J. C., Falace, D. A., Newburger, J. W., Gewitz, H.-S., Tong, D., Steckelberg, J. M., et al. (2007) · Cited by 3
Treatment Protocols for Bacterial Endocarditis and Infection of Electrophysiologic Cardiac Devices
Stryjewski, M. E., & Corey, G. R. (2005) · CRC Press eBooks · doi:10.1201/9781420028232-30 · Cited by 4
Staphylococcus aureus infective endocarditis at a tertiary Tunisian hospital. A changing profile?
Drissa, M., Amani, F., & Drissa, H. (2018) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2018.09.001 · Cited by 3
“aureus prosthetic valve infective endocarditis (SA PVIE) is a factor associated with high mortality rates reported in our study and several others.(25,26) As previously reported in published series devoted to right and left-sided native-valve SAIE,(10) heart failure is a powerful predictor of in-hospital mortality.”
BackgroundSáez, C., Sarriá, C., Vilacosta, I., Olmos, C., López, J., García-Granja, P. E., Fernández, C., Cuevas, C. D. L., Reyes, G., Domínguez, L., et al. (2019) · Medicine · doi:10.1097/md.0000000000016903 · Cited by 3
“Complications at the CNS were similar to that described in other studies, that is, 32% versus 27% to 35% during the entire course([3,4,34,44,48]) and 18% versus 15.”
BackgroundMethodResultInfluentialClinical Syndromes of Device-Associated Infections
Gerber, J. S., & Zaoutis, T. E. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00104-5 · Cited by 4
Jung, J., Hong, Y. S., Lee, C. J., Lim, S., Choi, H.-C., & Park, S.-J. (2013) · The Korean Journal of Thoracic and Cardiovascular Surgery · doi:10.5090/kjtcs.2013.46.3.208 · Cited by 2
“However, it is reported that central nervous system complications due to embolization is not an independent risk factor [8].”
BackgroundPrevention and Treatment of Infective Endocarditis
Stancoven, A., & Peterson, G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00043-6 · Cited by 2
Intracardiac Device and Prosthetic Infections: What Do We Know?
Johnston, B., & Conly, J. M. (2004) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2004/903428 · Cited by 2
“Risk factors for death were reviewed in 33 patients diagnosed with S aureus PVE between January 1975 and January 1983 (30).”
BackgroundInfluentialSurgical Treatment of Native Valve and Prosthetic Valve Infective Endocarditis
Brusch, J. L. (2007) · Infectious disease and therapy · doi:10.3109/9781420019834.015 · Cited by 2
Endocardites infectieuses gravesSerious infectious endocarditis.
Wolff, M. (2001) · Réanimation · doi:10.1016/s1164-6756(01)00116-5 · Cited by 2
Kneeshaw, J. D., & Feneck, R. O. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511730238.020 · Cited by 1
Issues in the management of endocarditis caused by resistant gram-positive organisms
Stryjewski, M. E., Chu, V. H. Y., Cabell, C. H., & Fowler, V. G. (2004) · Current Infectious Disease Reports · doi:10.1007/s11908-004-0049-7 · Cited by 1
Prothesenendokarditis - Inzidenz, Diagnostik und Therapie
Englberger, L., & Carrel, T. P. (2000) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s003980050003 · Cited by 4
“Wahrscheinliche Ursachen der Infektion sind in 25±80% der FaÈlle nachweisbar; am haÈufigsten finden sich darunter zahnaÈrztliche und urologische Eingriffe, urogenitale Infektionen sowie Infektionen bzw. diagnostisch/therapeutische Prozeduren im Gastrointestinaltrakt und am Integument oder auch eine intensivmedizinisch…”
BackgroundInfluentialIndications et moment de l’intervention chirurgicale dans l’endocardite infectieuse
Dzudié, A., Mercusot, A., de Gévigney, G., & Delahaye, F. (2008) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2008.02.012 · Cited by 2
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73540-6 · Cited by 3
(2009) · Springer eBooks · doi:10.1007/978-0-387-84841-9_11 · Cited by 1
Nagaratnam, N., Nagaratnam, K., & Cheuk, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-33434-9_7 · Cited by 1
Kaplan, S. L., & Vallejo, J. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00026-1 · Cited by 1
Diagnosis and Management of Infective Endocarditis
Camitta, M. G. W., Geme, J. W. S., & Li, J. S. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4619-3_4 · Cited by 1
Karchmer, A. W. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-918-9_31 · Cited by 1
Self-citationEndocarditis infecciosa: el papel de la cirugía
Beneyto, L. A. P., Luis, O. R., & Bayarri, V. M. (2010) · Medicina Clínica · doi:10.1016/j.medcli.2009.10.046 · Cited by 1
Guerrero, M. L. F., González‐López, J. J., Artiz, V., Górgolas, M., Martinell, J., Rey, M., & Fraile, J. (2010) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e3181e53828
“aureus.(5) At present, there is a consensus that patients with heart failure, myocardial abscesses, and other cardiac complications are considered candidates for valve replacement.”
BackgroundRole of Echocardiography in Guiding the Optimal Timing of Surgery in Infective Endocarditis
Reddy, S. M. L., Panaich, S., & Afonso, L. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0345-1 · Cited by 1
Management of infective endocarditis in children
Marwah, A., & Shrivastava, S. (2011) · Journal of Indian College of Cardiology · doi:10.1016/s1561-8811(11)80001-5 · Cited by 1
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
I NFECTIVE E NDOCARDITIS IN A DULTS
Ylonakis, E. L. M., & Alderwood, B. C. (2001)
Prosthetic Valve Endocarditis: To Operate or Not?
Britigan, B. E. (1998) · Journal watch · doi:10.1056/id199807010000012
Prevention and Treatment of Endocarditis
Peterson, G., & Cabell, C. H. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50050-4
Maréchaux, S., & Tribouilloy, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-32432-6_13 · Cited by 1
Cateslytin and Chromofungin, two CgA derived peptides actors of the immune and cardiac systems
Scavello, F. (2017) · theses.fr (ABES) · doi:10.70675/d13e8f68z4fb3z49e8z9103z34127e9a7050
“However, 50 mortality risk in S. aureus PVE remains high even with antibiotics therapy or surgical interventions (John et al., 1998; Attaran et al., 2012; Chu et al., 2015).”
BackgroundInfluentialLaser manufacturing of multi-functional and antibacterial surfaces for orthopaedic applications
McFadden, R. (2026) · Orthopaedic Proceedings · doi:10.17034/32631291
Cardiac Infections in the Pediatric Intensive Care Unit
Ibsen, L. M., & Shen, I. (2008) · Springer eBooks · doi:10.1007/978-1-84628-917-0_14
Staphylococcus aureus Bacteremia and Endocarditis
Kanafani, Z. A., Cosgrove, S. E., & Fowler, V. G. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch16
Isaacs, D., Elliott, E. J., Gilbert, R. E., Moyer, V. A., & Pichichero, M. E. (2007) · Wiley eBooks · doi:10.1002/9780470692172.ch3
Starke, J. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50037-6
Karchmer, A. W. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_30
Self-citationMatheson, E. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-239-1_13
Daghestani, L. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-036-0_13
Fullerton, D. A., & Grover, F. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5225-8.00081-7
Oxorn, D. C., & Otto, C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-0-7216-5356-3.50011-0
Clinical Syndromes of Device-Associated Infections
Huang, F. S., & Schaffzin, J. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00100-2
Prognosis and Follow-Up in Infective Endocarditis
Harb, S. C., & Hassan, O. K. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-65839-6_35 · Cited by 1
Gonçalves, A., Gonçalves, L. M. M., & Pinto, F. J. (2025) · Imprensa da Universidade de Coimbra eBooks · doi:10.14195/978-989-26-2420-4
Endocarditis in Oncology Patients
Cosgrove, S. E., & Subramanian, A. K. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_20
“Most patients with S. aureus PVE will require repeat valve replacement to optimize outcomes; therefore, cardiac surgeons should be involved in the patient’s care from the time of presentation [ 21 ].”
BackgroundInfluentialYeo, T. C. (2026) · Springer eBooks · doi:10.1007/978-981-96-7667-5_9
Metadata
- Authors
- John, M. D. V., Hibberd, P. L., Karchmer, A. W., Sleeper, L. A., & Calderwood, S. B.
- Affiliations
- Massachusetts General Hospital (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-06
- Volume
- 26
- Issue
- 6
- Pages
- 1302-1309
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2133760184
- Semantic Scholar
- 9d5f29d77f9c25c389602dd99ad9594bbabf8b6f
- Cited by
- 153
- References
- 25
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 2 · 2015: 10 · 2014: 3 · 2013: 10 · 2012: 5
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- Staphylococcus aureus, prosthetic valve endocarditis, mortality risk factors, valve replacement, cardiac complications, central nervous system complications, survival after diagnosis, antibiotic therapy, survivorship bias
- MeSH terms
- Adult, Aged, Endocarditis, Bacterial, Female, Heart Valve Prosthesis, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Staphylococcal Infections, Cohort Studies, Prosthesis-Related Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.